- Formula & Class: C10H16 — acyclic monoterpene; most abundant single terpene in most commercial cannabis varieties (20–65% of terpene profile)
- Aroma: Earthy, musky, herbal, ripe mango, damp soil — the quintessential cannabis base note
- Sedation mechanism: GABA-A receptor potentiation + adenosine receptor modulation (Do Vale 2002); dose-dependent sleep potentiation in animal models
- Blood-brain barrier: Myrcene hypothesized to increase BBB permeability, accelerating and intensifying THC brain entry (Russo 2011) — the scientific basis of the mango hypothesis
- Anti-inflammatory: COX-2 suppression and PGE2 inhibition (Lorenzetti 1991); osteoarthritis cartilage protection demonstrated in human chondrocytes
- Anti-mutagenic: Ames test data from Maistro 2010 — myrcene reduced mutagenicity of several chemical carcinogens in bacterial mutation assays
- Natural sources: Hops (Humulus lupulus — botanical cannabis relative, up to 65% EO), mango (0.5–3% EO), lemongrass, thyme, basil
What Is Myrcene?
Myrcene (beta-myrcene) is a naturally occurring acyclic monoterpene with the molecular formula C10H16. In pure form it is a pale yellow, oily liquid with an intensely herbal, musky fragrance most people immediately recognize from craft beer hops or ripe tropical fruit. As an acyclic monoterpene — meaning its carbon backbone does not form a ring structure — myrcene is structurally simpler than cyclic cannabis terpenes like limonene or terpinolene, but its pharmacological activity is among the most potent and diverse in the cannabis terpene library.
Within the cannabis plant, myrcene is biosynthesized in the secretory cells of trichomes — the glandular hairs that coat mature flower and sugar leaf surfaces — through the methylerythritol phosphate (MEP) pathway. Myrcene synthase acts on geranyl pyrophosphate (GPP) to produce myrcene in a direct, single-step reaction. Because the same GPP substrate feeds all cannabis monoterpene synthases, strains with high myrcene synthase expression tend to have elevated myrcene at the expense of competing monoterpenes. This metabolic competition means that very-high-myrcene strains (above 1% total terpene content) often show relatively low limonene and pinene, reflecting the competitive allocation of the shared GPP pool.
Myrcene is one of the most abundant terpenes in the plant kingdom. Hops (Humulus lupulus) — a close botanical relative of cannabis in the Cannabaceae family — can contain myrcene at concentrations as high as 65% of their essential oil fraction. This botanical kinship explains why certain cannabis strains and hoppy IPAs share strikingly similar aromatic profiles. The relationship is not coincidental: cannabis and hops diverged from a common ancestor relatively recently in evolutionary terms and retained overlapping terpene biosynthetic machinery. Mango (Mangifera indica) — the source of the famous mango hypothesis — contains 0.5–3% myrcene in ripe fruit essential oil. Lemongrass, thyme, basil, and bay laurel are additional significant dietary myrcene sources.
Myrcene’s commercial importance extends far beyond cannabis. It is used as a flavor component in beverages, confectionery, and food products (FDA GRAS status), as a fragrance note in perfumes and household products, and as a chemical synthesis intermediate for production of menthol, geraniol, nerol, and other higher-value terpene derivatives. This commercial significance has driven extensive safety characterization and quality standardization, giving myrcene one of the most thoroughly documented safety profiles of any cannabis terpene.
Chemical Properties
| Property | Detail |
|---|---|
| IUPAC Name | (E)-7-methyl-3-methyleneocta-1,6-diene (beta-myrcene) |
| Molecular Formula | C10H16 |
| Molecular Weight | 136.23 g/mol |
| Boiling Point | 167°C (332°F) |
| Appearance | Pale yellow oily liquid |
| Aroma | Earthy, musky, herbal, mango, damp soil |
| Solubility | Practically insoluble in water; miscible with ethanol, ether, oils |
| Cannabis Concentration | 0.1–3.0%+ of total terpene fraction; 20–65% of terpene profile in high-myrcene strains |
| FDA Status | GRAS (Generally Recognized As Safe) as food flavoring |
Biosynthesis: MEP Pathway and Terpene Competition
Myrcene is synthesized in cannabis trichomes via the MEP (methylerythritol phosphate) pathway, the plastidial route that supplies isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) for monoterpene production. Geranyl pyrophosphate synthase condenses one IPP and one DMAPP unit to form GPP, the universal C10 monoterpene precursor. Myrcene synthase then converts GPP to myrcene through a simple ionization-proton elimination mechanism, producing myrcene’s characteristic triene structure (three carbon-carbon double bonds) without cyclization.
Myrcene synthase efficiency and expression level are the primary determinants of a strain’s myrcene concentration. Cannabis genetics research has identified several quantitative trait loci (QTL) associated with myrcene content, and terpene-focused breeding programs increasingly use genomic selection to develop high-myrcene cultivars for the medical and recreational markets that favor heavy indica-style sedation. The “above 0.5% myrcene = indica-type sedation” rule of thumb widely cited in the cannabis industry is derived from consumer survey data and aligns with the dose-dependency observed in animal sedation research.
Mechanism of Action and Receptor Targets
GABA-A Receptor Potentiation: The primary sedative mechanism of myrcene is positive allosteric modulation of GABA-A receptors — the same family of inhibitory chloride-channel receptors targeted by benzodiazepines, barbiturates, and alcohol. GABA-A potentiation reduces neuronal firing rates across the CNS, producing the characteristic physical relaxation, muscle loosening, and sedation associated with high-myrcene cannabis. Do Vale et al. (2002) demonstrated this mechanism in lemon verbena essential oil sedation studies, and subsequent research has attributed the primary sedative activity in that oil specifically to its myrcene content.
Adenosine Receptor Modulation: Myrcene has demonstrated activity at adenosine receptors, particularly A1 and A2A subtypes. Adenosine A1 agonism produces sedation and analgesia; A2A modulation affects dopaminergic tone in the striatum, potentially contributing to myrcene’s influence on the character of the cannabis high beyond simple sedation. The interaction between adenosine pathway activity and cannabinoid receptor activity is an active area of cannabis pharmacology research.
Blood-Brain Barrier Permeabilization: Russo’s 2011 entourage effect review proposed, based on mechanistic reasoning and anecdotal evidence, that myrcene increases cell membrane permeability — including the blood-brain barrier — thereby facilitating faster and more complete CNS entry of THC and other cannabinoids. This hypothesis provides a coherent mechanistic explanation for the empirical observation that high-myrcene strains often produce more intense effects than equivalent-THC lower-myrcene strains, and it underpins the mango hypothesis. Direct clinical evidence in humans remains limited, but the mechanistic basis is pharmacologically credible.
Endogenous Opioid Activation: Rao et al. (2003) demonstrated that myrcene-induced analgesia in animal spinal cord models was partially blocked by naloxone (an opioid antagonist), suggesting that myrcene activates endogenous opioid pathways (enkephalins, beta-endorphin) contributing to its analgesic effects. This mechanism complements COX-2 inhibition and GABA-A mediated pain modulation, creating a multi-mechanism analgesic profile.
Medical Evidence
| Study | Model | Dose / Administration | Outcome | Evidence Quality |
|---|---|---|---|---|
| Do Vale et al., 2002 | Mice (sedation model) | Lemon verbena EO (high myrcene) oral | Dose-dependent sedation; significant pentobarbital sleep-time potentiation; GABA-A mechanism identified | Moderate (animal) |
| Lorenzetti et al., 1991 | Mouse pain / inflammation models | 200 mg/kg oral myrcene | Inhibited PGE2 production via COX-2 suppression; anti-inflammatory and analgesic activity confirmed | Moderate (animal) |
| Rao et al., 2003 | Spinal cord pain model (mice) | 20–200 mg/kg i.p. | Antinociception via GABA-A spinal mechanism and endogenous opioid activation (naloxone-reversible component) | Moderate (animal) |
| Rufino et al., 2015 | Human chondrocytes (OA model) | In vitro myrcene exposure | Reduced cartilage-degrading matrix metalloproteinase (MMP) expression; anti-osteoarthritis mechanism | Moderate (in vitro human cells) |
| Maistro et al., 2010 | Salmonella Ames test | Standard mutagenicity protocol | Myrcene reduced mutagenicity of several tested carcinogens; anti-mutagenic activity confirmed | Moderate (in vitro) |
| Russo, 2011 (review) | Mechanistic entourage review | BBB permeability hypothesis; myrcene as primary sedative terpene; entourage effect framework formalized | Moderate (review / expert synthesis) | |
| da Silva et al., 2015 | Leishmania donovani (parasite) | In vitro | Anti-leishmanial activity demonstrated; mechanism involves disruption of parasite membrane integrity | Preliminary (in vitro) |
Top Cannabis Strains High in Myrcene
Myrcene-dominant strains encompass the majority of classic indica and indica-dominant hybrid cultivars. High myrcene content is the most reliable single predictor of heavy, sedating, couch-lock cannabis effects available from terpene analysis.
| Strain | Type | Myrcene % | Co-Terpenes | Effect Profile |
|---|---|---|---|---|
| 9 Pound Hammer | Pure Indica | 1.00–1.40% | Caryophyllene, myrcene-dominates | Heaviest sedation, full-body lock, sleep |
| Granddaddy Purple | Pure Indica | 0.90–1.20% | Caryophyllene, pinene, linalool | Deep sedation, euphoria, classic indica |
| Mango Kush | Indica-dominant Hybrid | 0.85–1.15% | Caryophyllene, pinene | Body relaxation, sweet mango, mood lift |
| OG Kush | Indica-dominant Hybrid | 0.75–1.10% | Limonene, caryophyllene | Stress relief, euphoria, earthy musk |
| Purple Urkle | Pure Indica | 0.80–1.10% | Caryophyllene, linalool | Sleepiness, full-body calm, grape-earth |
| Wedding Cake | Indica-dominant Hybrid | 0.70–1.00% | Limonene, caryophyllene, linalool | Euphoria, physical ease, relaxation |
| Blue Dream | Sativa-dominant Hybrid | 0.60–0.90% | Caryophyllene, pinene, terpinolene | Balanced relaxation, creativity |
| Remedy (High CBD) | High-CBD Indica | 0.65–0.95% | Myrcene + CBD primary | Anti-anxiety, muscle relief, clear-headed |
| Jillybean | Sativa-dominant Hybrid | 0.50–0.80% | Ocimene, terpinolene, myrcene | Uplifting body-effect, citrus-mango |
Entourage Effect Synergies
| Partner Compound | Interaction Type | Combined Effect |
|---|---|---|
| THC | BBB permeabilization + sedation amplification | Myrcene hypothesized BBB permeability increase accelerates and intensifies THC brain entry; combined CNS depression produces classic couch-lock |
| CBD | Additive anti-inflammatory + complementary sedation | CBD anti-inflammatory (CB2, PPARs) + myrcene COX-2 inhibition = broad anti-inflammatory stack; CBD anxiolytic + myrcene sedation = non-intoxicating relaxation profile |
| Caryophyllene | Pain relief synergy | Myrcene opioid/GABA-A analgesia + caryophyllene CB2 anti-inflammatory = multi-mechanism pain coverage; OG Kush profile |
| Linalool | Additive sedation / anti-anxiety | Both potentiate GABA-A activity through partially overlapping mechanisms; combined effect produces deeper sedation and anxiolysis than either alone |
| Pinene | Counterbalancing (memory) | Alpha-pinene AChE inhibition (memory preservation) partially offsets myrcene-mediated BBB/THC intensification; explains why some high-pinene strains feel less cognitively impairing despite high THC |
Non-Cannabis Natural Sources
Hops (Humulus lupulus) represent the highest-concentration dietary myrcene source, with up to 65% of hop cone essential oil comprising myrcene in certain high-myrcene hop varieties used in IPA brewing. The botanical relatedness of hops and cannabis — both members of Cannabaceae — makes this the most directly parallel natural source. Mango (Mangifera indica) ripe fruit essential oil contains 0.5–3% myrcene, sufficient to provide a physiologically meaningful myrcene dose when consuming a whole mango — the scientific basis of the mango hypothesis. Lemongrass (Cymbopogon citratus) contains 15–25% myrcene in essential oil and is widely used in Southeast Asian cuisine and herbal tea preparations, making it the most common dietary myrcene source globally. Thyme, basil, bay laurel, and ylang-ylang flower all contain myrcene at 1–10% of essential oil.
Commercial Uses
Terpene Synthesis Intermediate: Myrcene is commercially significant as a chemical synthesis intermediate for production of higher-value terpene derivatives. Industrial oxidation and rearrangement reactions convert myrcene to geraniol, nerol, linalool, citronellol, and menthol — all commercially important flavor, fragrance, and pharmaceutical compounds. This makes myrcene a true terpene platform molecule and one of the most industrially important plant terpenes worldwide.
Flavor and Fragrance: FDA GRAS-listed myrcene is used as a flavoring agent in beer (hoppy accords), fruit-flavored beverages, and confectionery. In fragrance, it contributes herbal, earthy base notes to green and woody fragrance accords.
Cannabis Product Formulation: As the most abundant cannabis terpene, myrcene is increasingly used as a restoring terpene in distillate-based cannabis products where terpenes have been removed during extraction and must be added back to restore the expected flavor and effect profile. Its sedation-linked pharmacology makes it a priority addition for sleep and relaxation product formulations.
Safety and Toxicology
Myrcene has GRAS status as a food flavoring agent (FDA) and is considered safe at food and aromatherapy exposure levels. Acute oral toxicity in animal models is low (LD50 approximately 4.7 g/kg in rats). No carcinogenicity or reproductive toxicity has been identified in standard safety studies. High-dose exposure in rodent studies showed some evidence of liver enzyme induction (CYP enzyme upregulation), but the relevance of these findings to typical cannabis consumption exposure levels is considered minimal by current regulatory consensus. No significant dermal sensitization potential at typical fragrance use levels. Individuals with severe chemical sensitivities may experience irritation from concentrated terpene exposure, but this applies to all volatile organic compound exposure rather than being myrcene-specific.
Frequently Asked Questions
What does myrcene smell like in cannabis?
Myrcene produces an earthy, musky, herbal aroma often compared to damp soil, ripe mango, or cloves. In cannabis, high myrcene gives strains like OG Kush and Granddaddy Purple their deeply pungent, funky, musky base character. Hops — a botanical relative in the Cannabaceae family — can contain up to 65% myrcene in essential oil, which is why hoppy IPAs share cannabis’s dank aroma.
Does myrcene cause sedation and couch-lock?
Yes — myrcene is the most consistently sedating cannabis terpene. Its primary mechanism is GABA-A receptor potentiation (Do Vale 2002) combined with adenosine receptor modulation. Above approximately 0.5% of a strain’s terpene content, myrcene is reliably associated with heavy physical relaxation and couch-lock effects. Its BBB permeabilizing effect may intensify and accelerate THC’s own sedative contributions.
Can eating mango amplify cannabis effects?
The mango hypothesis has genuine pharmacological plausibility. Ripe mangoes contain 0.5–3% myrcene in essential oil. Myrcene’s proposed blood-brain barrier permeabilizing effect (Russo 2011) would facilitate faster and more complete THC brain entry. Many consumers report subjectively faster onset and more intense effects after eating mango before cannabis, consistent with this mechanism, though controlled human clinical trials are still limited.
What strains are highest in myrcene?
The highest-myrcene strains include 9 Pound Hammer (1.00–1.40%), Granddaddy Purple (0.90–1.20%), Mango Kush (0.85–1.15%), and OG Kush (0.75–1.10%). Classic indica and indica-dominant hybrids consistently test highest. Myrcene comprises 20–65% of the total terpene profile in many commercial cannabis varieties.